NABL, CAP, ISO
Overview of Plasminogen Activator Inhibitor-1
What is Plasminogen Activator Inhibitor-1?
The Plasminogen Activator Inhibitor-1 (PAI-1) test is performed to keep a check on the PAI-1 protein as high PAI-1 depresses fibrionolytic activity which leads to an increased probability of venous and arterial thrombosis. On the other hand, deficiency of PAI-1 can lead to excessive bleeding due to any injury.
Why is Plasminogen Activator Inhibitor-1 done?
PAI-1 deficiency causes excessive bleeding due to any injury or physical trauma. If left undetected, the PAI-1 level may reduce even further and that can even prove to be fatal in the worst case.
Preparation for Plasminogen Activator Inhibitor-1
- Do not eat or drink anything other than water for 8-12 hours before the test.
Sample Type for Plasminogen Activator Inhibitor-1
The sample type collected for Plasminogen Activator Inhibitor-1 is: Blood
Interpreting Plasminogen Activator Inhibitor-1 results
The normal PAI-1 range is 2-15 AU/mL.
We focus on providing patients quality diagnostic healthcare services in India. Through our network, we offer patients convenient locations for their diagnostic healthcare services and efficient service. With over 3368 diagnostic and related healthcare tests and services offered, we believe we are capable of performing substantially all of the diagnostic healthcare tests and services currently prescribed by physicians in India. Our key competitive strengths are: Business model focused on the patient as a customer and an established consumer healthcare brand associated with quality services, in a market where patients generally choose their diagnostic healthcare service provider. Well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry. A network whose growth yields greater economies of scale, combined with a hub and spoke model that is scalable for further growth. Centralized information technology platform that fully integrates our network and is scalable. Attractive financial performance, financial profile and return on invested capital. Experienced leadership team with strong industry expertise and successful track record. Some of our laboratories have achieved International Organization for Standardization, or ISO, certification for their quality systems. Our National Reference Laboratory has obtained ISO 9001:2008 certification (for the performance of routine and advanced diagnostic pathology testing services, including clinical trials), ISO 15189:2007 (for quality management in medical laboratories), ISO 15189:2012 certification (in the field of medical testing) and ISO 27001:2013 certification (for establishing an effective information management system that maintains and processes information security at our data center).